Joseph Bratica
Net Worth
Last updated:
What is Joseph Bratica net worth?
The estimated net worth of Mr. Joseph Bratica is at least $2,353,722 as of 11 Dec 2020. He owns shares worth $161,172 as insider and has received compensation worth at least $2,192,550 in Sarepta Therapeutics, Inc..
What is the salary of Joseph Bratica?
Mr. Joseph Bratica salary is $438,510 per year as Controller & Vice President in Sarepta Therapeutics, Inc..
What stocks does Joseph Bratica currently own?
As insider, Mr. Joseph Bratica owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | Controller & Vice President | 8,140 | $19.8 | $161,172 |
What does Sarepta Therapeutics, Inc. do?
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; and VYONDYS 53 for the treatment of duchenne in patients with confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping. The company is also developing AMONDYS 45, a product candidate that uses phosphorodiamidate morpholino oligomer chemistry and exon-skipping technology to skip exon 45 of the dystrophin gene; SRP-5051, a peptide conjugated PMO that binds exon 51 of dystrophin pre-mRNA; SRP-9001, a DMD micro-dystrophin gene therapy program; and SRP-9003, a limb-girdle muscular dystrophies gene therapy program. It has collaboration agreements with F. Hoffman-La Roche Ltd; Nationwide Children's Hospital; Lysogene; Duke University; Genethon; and StrideBio. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.
Joseph Bratica insider trading
Sarepta Therapeutics, Inc.
Mr. Joseph Bratica has made 3 insider trades in 2020, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 1,125 units of SRPT stock on 3 Aug 2020. As of 11 Dec 2020 he still owns at least 8,140 units of SRPT stock.